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Background: Cystoscopy evokes discomfort and pain, especially in males. The cystoscopic retrograde approach is
standard in the removal of ureteral stents. However the satisfaction and degree of pain during the procedure
according to the use of several pain controlling methods are unclear.
Methods: This is a cross-sectional survey of 60 patients who underwent cystoscopic ureteral stent removal under
intravenous analgesics (group 1, n = 20), midazolam induction (group 2, n = 20), and propofol (group 3, n = 20).
Procedural pain and post-procedure satisfaction were determined, and cost differences between the approaches
were clarified.
Results: Group 2 and 3 showed significantly less pain than group 1 (P < 0.001) and significantly higher satisfaction
rate than group 1 (P < 0.001). Comparison of groups 2 and 3 revealed showed significantly less pain and higher
satisfaction rate in group 3 (P < 0.001 for both). In Group 1, 17 (85.0%) patients wanted other treatment modalities,
compared to eight group 2 patients (40.0%) and no group 3 patients.
Conclusions: Considering the potential pain and dissatisfaction of rigid cystoscopic ureteral stent removal,
procedures utilizing moderate sedation with midazolam or general anesthesia using propofol without muscle
relaxation should be considered.
Trial registration: KCT0001260.
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Although the real benefit of ureteral stenting after ure-
teroscopic removal of stone (URS) is contentious, the
chance with ureteral stenting following ureteroscopic re-
moval of stone is frequent [1]. After URS, ureteral stents
are removed at post-operative 1 or 2 weeks, typically by
cystoscopic retrograde removal [2,3]. However, because
of the rigidity and larger diameter of cystoscopes, most
patients need analgesia and some patients need deep
sedation during the procedure [2,3]. In real practice,
those stents are removed mostly in the outpatient setting
using urethral lubrication jelly with or without narcotic
intramuscular premedication [4-6].
Recently, lubrication jelly and lidocaine injection were
reported to be no more effective for pain control during* Correspondence: yssong@schmc.ac.kr
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unless otherwise stated.cystoscopy [7-11]. A flexible cystoscopy is a good alter-
native to rigid cystoscopy to reduce pain during proced-
ure, but flexible cystoscopy is less available in korea and
moreover there have been little reports about ureteral
stent removal with flexible cystoscopy.
There have been many studies about pain during rigid
or flexible cystoscopy, but there have been few studies
about pain during cystoscopic stent removal. Although
shorter in duration than cystoscopy, cystoscopic stent
removal yields a similar pain to cystoscopy, and more-
over larger diameter of rigid cystoscopy is needed for
use of foreign body forceps. In our previous pilot study,
cystoscopy using midazolam produced marginally greater
satisfaction among men [6]. This is the main reason why
we adapted diverse pain controlling method including
propofol. The aim of this prospective, randomized, pilot
study was to compare the satisfaction about cystoscopic
stent removal according to different pain relief methods
and to compare the costs.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Study sample
From September 2012 to March 2013, 60 male patients
with a history of prior URS and ureteral stenting due to
ureteral stone were enrolled. Informed consent was
obtained from all patients. The mean age of patients was
47.45 years. Subjects with severe cardiovascular disease,
pulmonary disease, liver disease, and drug abuse history
were excluded as were patients with a prior cystoscopy
procedure were excluded. The 60 patients were sub-
classified randomly according to several pain control-
ling methods: cystoscopy + intravenous (IV) analgesics
(group 1, n = 20); cystoscopy + midazolam (group 2,
n = 20); and cystoscopy + propofol (group 3, n = 20).
This study was approved by Institutional review board
of Soonchunhyang University Hospital. Trial registration
KCT0001260.
Procedures
All patients were placed in the dorsolithotomy position
in the operation room. The same two urological sur-
geons (Jae Heon Kim and Yun Seob Song) performed all
cystoscopic ureteral stent removals using a 17.5 Fr rigid
cystoscope. Prior to the procedure, the urethra was in-
stilled with 2% lidocaine topical jelly. After 5–10 min,
the cystoscope was introduced to the urethra and blad-
der, and the ureteral stent was removed using foreign body
forceps. In the operating room, electrocaridography, non-
invasive blood pressure monitoring, and pulse oximetry
monitoring were done. Vital signs were checked during
the procedure and after the procedure in the day care unit.
The presence of complications including oxygen desatur-
ation, autonomic movement, arrythmia, injection pain,
and phlebitis were also examined. Before discharge, the
patients were asked to rate their comfort level using a vis-
ual analog scale (VAS) and satisfaction scale, detailed in
the Additional file 1. Recovery from sedation was assessed
by the mini-mental state examination (MMSE).
IV administration of ketorolac
Intravenous analgesic administration was performed
after lidocaine jelly instillation into the urethra. Intraven-
ous administration of ketorolac 30 mg was used for pain
control. Before discharge, the patients were asked to rate
their comfort level as described above.
Moderate sedation with midazolam
Midazolam with doses of 3-5 mg (no more than
0.03 mg/kg) was administrated to the subjects after lido-
caine jelly instillation. The status of sedation was mea-
sured and divided according to five stages, as described in
the Additional file 1. Cystoscopy was started when the
stage was over three. After the procedure was finished, the
midzolam antidote, flumazenil was administrated.After the procedure, the patient was transferred to day
care unit and was discharged when they displayed nor-
mal orientation of time and space with vital signs within
the normal range.
Deep sedation with propofol
Patients received an injection of 0.2 mg glycopyrollate
about 20 min before induction of deep sedation. Sed-
ation was induced with propofol 2 mg/kg without
muscle relaxation and was maintained using propofol
10 mg/kg/h. After induction, the anesthesiologist applied
a face mask and assisted with ventilation with 100% O2.
After the procedure, the patient was transferred to day
care unit and was discharged when they displayed nor-
mal orientation of time and space with vital signs within
the normal range.
Cost calculation
Cost was described as medical insurance fee and real pa-
tient expense. In Korea, due to National Medical Insur-
ance system, a patient may pay 20-100% of total medical
insurance fee. Rate of exchange between Korea Won
and the US dollar was 1120.6 won for 1 dollar.
Treatment satisfaction
The treatment satisfaction questionnaire included five
subscales: “very satisfied”, “satisfied”, “average”, “not sat-
isfied”, and “totally not satisfied”. These subscales were
divided into two groups: “Satisfactory” included “very
satisfied” and “satisfied”, and “Not satisfactory” included
“average”, “not satisfied”, and “totally not satisfied”.
Questionnaire about seeking another method
After the procedure, a questionnaire solicited responses
about seeking other pain controlling method. The ques-
tion asked was “Do you prefer another pain controlling
method if it were effective although you could pay more?”
Statistical analyses
Data were analyzed using SAS version 9.1 (SAS Institute,
Cary, NC, USA). The Kolmogorov-Smirnov test was
used to verify the normality of distribution of continuous
variables. Nonparametric tests of comparison were used
for variables evaluated as not normally distributed. Me-
dian and minimal to maximal range were used as appro-
priate to describe statistics. Difference testing between
groups was performed using Kruskal-Wallis test and
Mann–Whitney test as appropriate.
Results
There was no significant difference among blood pres-
sure, pulse rate, O2 saturation during the procedure in-
cluding those 3 different methods. The differences of
pre-operative and post-operative MMSEs including pre-
Table 1 Satisfaction and pain scores among the three groups
Group 1 Group 2 Group 3 P value
Age 49.50 (26–70) 47.50 (15–70) 49.50 (29–72) 0.731
BMI 26.5 (19.8-31.2) 25.6 (21.4-28.3) 26.0 (22.6-29.4) 0.361
Time duration (min) 11.3 (8.6-30.5) 32.6 (29.6-40.5) 50.4 (45.3-75.4) 0.021
Duaration of procedure (min) 2.3 (1.5-3.3) 2.4 (1.3-3.4) 2.2 (1.0-3.2) 0.243
VAS 8.00 (6–10)*,† 5.00 (1–7)†,‡ 0.00 (0–1)*,‡ <0.001
Satisfaction 1 (0–3)*,† 3 (1–5)†,‡ 5 (4–5)*,‡ <0.001
Willing to undergo the procedure (VAS) 2 (0–4)*,† 5 (4–8)†,‡ 7 (6–9)*,‡ <0.001
Group 1, Cystoscopy + IV analgesics, Group 2, Cystoscopy +midazolam, Group 3, Cystoscopy + propofol, BMI Body mass index, VAS Visual analog pain scale.
Time duration procuedural time + recovery time.
Data are expressed as median number with minimum to maximum number.
P values were analyzed by Kruskal-Wallis test.
*,†,‡:significant differences by Post hoc analysis.
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three groups. The time duration including procedural
time and recovery time showed longer in group 2 and 3
than group1 (Table 1).
Group 1 experienced more pain and more dissatisfac-
tion with the procedure than group 2 and group 3. VAS
of group 1 was higher than that of group 2 and group 3
(P <0.001) (Table 1). Satisfaction scale of group 1 was
lower than that of group 2 and group 3 (P <0.001)
(Table 1). Comparison of group 2 and 3 revealed lower
VAS in group 3 (P <0.001) and higher satisfaction rate in
group 3 (P < 0.001) (Figures 1 and 2).Figure 1 Comparison of VAS among group 1 (cystoscopy + IV analgesi
general anesthesia using propofol).Total medical insurance fee for group 1, 2, and 3 was
US102.63, US108.65, and US218.47, respectively (Table 2).
For real patient expense, the cost in the same respective
order was US57.94, US61.55, and US119.98 (Table 2). De-
tailed expenses are provided in Table 2.
Comparison of groups 2 and 3 revealed less pain and
higher satisfaction rate in group 3 (P <0.001 for both). In
group1, 17 (85%) patients wanted other treatment mo-
dalities, whereas in eight of group 2 patients (40%) and
no group 3 patients wanted other treatment modalities.
Group 1 revealed lower VAS score of willing to undergo
the procedure again than group 2 and group 3 (<0.001).cs), group 2 (cystoscopy +midazolam), and group 3 (cystoscopy +
Figure 2 Comparison of satisfaction among group 1 (cystoscopy + IV analgesics), group 2 (cystoscopy +midazolam), and group 3
(cystoscopy + general anesthesia using propofol.
Table 2 Cost expenses among the three groups
Group 1 Group 2 Group 3
Cost (won) Patient expense (won) Cost (won) Patient expense (won) Cost (won) Patient expense (won)
Fee for procedure 75,647 45,388 75,647 45,388 75,647 45,388
Consultation fee 13,090 13,090 13,090 13,090 13,090 13,090
Normal saline 1 L 1,099 659 1,099 659 1,099 659
Intravenous injection fee 3,315 663 3,315 663 6,630 1,326
Day care unit 38000 38000




IV NSAIDs 1,889 1,134
Blood O2 saturation monitoring 5,490 1,098 5,490 1,098
ECG monitoring 6,460 1,292 6,460 1,292
Blood pressure monitoring 8,020 1,604 8,020 1,604
Total costs (won) 115,010 64,928 121,750 68970 244,814 134,451
Total costs (US dollar) 102.63 57.94 108.65 61.55 218.47 119.98
Gourp 1 Cystoscopy + IV analgesics, Group 2 Cystoscopy +midazolam, Group 3 Cystoscopy + propofol, ECG electrocardiography, NSAIDS non-steroidal
anti-inflammatory drugs.
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undergo the procedure again than group 3 (<0.001)
(Table 1).
Discussion
Cystscopy is the standard technique used to removal or ex-
change a ureteral stent. In addition to the large diameter of
cystoscopies, which can induce pain, several conditions
make this technique more difficult, especially in male pa-
tients, due to the longer urethra and prostatic enlargement.
Several retrograde methods without conventional cyst-
oscopy have been developed [7-10]. Successful outcomes
have been reported using retrograde ureteral stent re-
moval or change under fluoroscopic guidance, but most
patients in these studies were female, and only one study
included male patients [10].
Ureteroscopy is one of the most common methods to
treat urinary stones [11]. In many cases, ureteral stent
insertion follows ureteroscopy [1]. Although cystoscopic
ureteral stent removal is common, discomfort associated
with the procedure is unclear. Our study is the first clin-
ical trial to address this issue.
Local anesthesia has long been used in men undergo-
ing rigid cystoscopy. Recent reports indicated that lido-
caine gel has no effect on pain during cystoscopy [7-11].
The diverse efficacy of lidocaine gel may be because the
absorption of topical lidocaine is slow and incomplete.
Several groups have demonstrated that maximal lido-
caine absorption requires 15 to 60 minutes [5,12].
To overcome this limited effect of lidocaine jelly, sev-
eral methods have been introduced such as sleep induc-
tion using midazolam, pain killers, or listening to music
[4,6,13]. Midazolam is a well-known sedative drug with
amnesic properties. Previous studies have demonstrated
that midazolam can yield anterograde amnesia without
retrograde amnesia [14-17]. Midazolam produces the im-
mediate onset of anterograde amnesia in patients, which
could be useful in forgetting the painful events [14].
One of the prominent features of our study was that,
for the first time, we adapted a propofol in cystoscopy or
cysoscopic ureteral stent removal. Propofol is safe and
effective during gastrointestinal endoscopy procedures
[18,19]. Moreover, it has been associated with shorter re-
covery time, better sedation, and lack of a harmful effect
on cardiopulmonary function. Our study showed that
both the group with midazolam and propofol showed
longer time duration but the differences were not large.
Considering the nature of pilot study to use propofol, we
had assistance of anesthetic department for safety. In the
future, the procedures using propofol might be feasible
in outpatient department.
In this study, the satisfaction was the greatest in the
group with using propofol. Cystoscopic procedure with
IV pain killers was not effective at all. Procedures usingmidazolam yielded less pain and greater satisfaction than
procedures with IV pain relievers. Patients treated with
propofol reported the greatest satisfaction despite spend-
ing additional recovery time in the day care unit.
Moreover, the gap of real expense among the three
groups was not large. This is might be due to a unique
medical insurance system in Korea. The gap difference
of cost should be validated in other countries with dif-
ferent medical systems.
The present study has several limitations. We did not
assess the pain felt by patients during each step of the
procedure. Moreover, the sample size was relatively
small, and the study was not blinded for patients and
physicians, which could result in some bias in data inter-
pretation or reporting of satisfaction and pain levels.
Second, the sample size was relatively small but owing
to its nature of pilot study, the differences of main out-
comes among each groups were definite.
Conclusions
Urologists have to pay more concern to cystscopic ureteral
stent removal. With the traditional methods of lidocaine
jelly and pain killers, patients have to suffer from pain and
discomfort. Midazolam and propofol could be a options to
control both. Considering the safety and the high preva-
lence of use of midazolam and propofol, urologists should
not hesitate to adapt new methods in pain control during
cystoscopic ureteral stent removal.
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